Evidence map›Paper›PMID 25689822›Full record

ArticlePloS one2015

Adventitial vessel growth and progenitor cells activation in an ex vivo culture system mimicking human saphenous vein wall strain after coronary artery bypass grafting.

Francesca Prandi, Marco Piola, Monica Soncini, Claudia Colussi, Yuri D'Alessandra, Eleonora Penza, Marco Agrifoglio, Maria Cristina Vinci, Gianluca Polvani, Carlo Gaetano and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Human Cell Modeling for Cardiovascular Diseases.International journal of molecular sciences · 2020
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Mechanotransduction in Coronary Vein Graft Disease.Frontiers in cardiovascular medicine · 2018
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Francesca PrandiUnità di Ingegneria Tissutale, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Marco PiolaPolitecnico di Milano, Dipartimento di Elettronica, Informazione e Bioingegneria, Milan, Italy.
Monica SonciniPolitecnico di Milano, Dipartimento di Elettronica, Informazione e Bioingegneria, Milan, Italy.
Claudia ColussiIstituto di Patologia Medica, Università Cattolica del Sacro Cuore, Rome, Italy.
Yuri D'AlessandraUnità di Immunologia e Genomica Funzionale, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Eleonora PenzaII Divisione di Cardiochirurgia, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Marco AgrifoglioDipartimento di Scienze Cliniche e di Comunità, Università di Milano, Milan, Italy.
Maria Cristina VinciUnità di Ingegneria Tissutale, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Gianluca PolvaniDipartimento di Scienze Cliniche e di Comunità, Università di Milano, Milan, Italy.
Carlo GaetanoDivision of Cardiovascular Epigenetics, Goethe University, Frankfurt-am-Main, Germany.
Gianfranco Beniamino FiorePolitecnico di Milano, Dipartimento di Elettronica, Informazione e Bioingegneria, Milan, Italy.
Maurizio PesceUnità di Ingegneria Tissutale, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Centro Cardiologico Monzino · ITPolitecnico di Milano · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Milan · ITGoethe University Frankfurt · DEUniversità Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Saphenous vein graft disease is a timely problem in coronary artery bypass grafting. Indeed, after exposure of the vein to arterial blood flow, a progressive modification in the wall begins, due to proliferation of smooth muscle cells in the intima. As a consequence, the graft progressively occludes and this leads to recurrent ischemia. In the present study we employed a novel ex vivo culture system to assess the biological effects of arterial-like pressure on the human saphenous vein structure and physiology, and to compare the results to those achieved in the presence of a constant low pressure and flow mimicking the physiologic vein perfusion. While under both conditions we found an activation of Matrix Metallo-Proteases 2/9 and of microRNAs-21/146a/221, a specific effect of the arterial-like pressure was observed. This consisted in a marked geometrical remodeling, in the suppression of Tissue Inhibitor of Metallo-Protease-1, in the enhanced expression of TGF-β1 and BMP-2 mRNAs and, finally, in the upregulation of microRNAs-138/200b/200c. In addition, the veins exposed to arterial-like pressure showed an increase in the density of the adventitial vasa vasorum and of cells co-expressing NG2, CD44 and SM22α markers in the adventitia. Cells with nuclear expression of Sox-10, a transcription factor characterizing multipotent vascular stem cells, were finally found in adventitial vessels. Our findings suggest, for the first time, a role of arterial-like wall strain in the activation of pro-pathologic pathways resulting in adventitial vessels growth, activation of vasa vasorum cells, and upregulation of specific gene products associated to vascular remodeling and inflammation.

Indexed as

Stress, MechanicalAdventitiaBiomechanical PhenomenaBlood CirculationCells, CulturedConstriction, PathologicCoronary Artery BypassGene Expression RegulationHumansMicroRNAsPostoperative ComplicationsRNA, MessengerSaphenous VeinStem CellsMicroRNAsRNA, Messenger

Identifiers

PMID25689822
PMCPMC4331547
OpenAlexW2006188909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.